Immunotherapy, a revolutionary approach in cancer treatment, has reshaped the medical landscape, offering new hope to patients with a variety of malignancies. This article provides a comprehensive guide to understanding the principles and applications of immunotherapy.
Immunotherapy works by harnessing the patient's immune system to fight cancer. It either stimulates the immune system to work harder or provides it with artificial immune system proteins. Two main types of immunotherapy are checkpoint inhibitors and CAR T-cell therapy. Checkpoint inhibitors block proteins that stop the immune system from attacking cancer cells, while CAR T-cell therapy involves modifying patients' immune cells to become more effective in combating cancer.
Immunotherapy has demonstrated efficacy in treating a variety of cancers, including melanoma, lung, bladder, and kidney cancers. It is also used in hematological malignancies such as lymphoma. The choice of immunotherapy depends on several factors, including the type of cancer, the stage of the disease, and the patient's overall health status.
Despite its potential, immunotherapy presents several challenges. These include the risk of severe immune-related adverse events and the high cost of treatment. Moreover, not all patients respond to immunotherapy, and predicting who will benefit remains a significant challenge. Future research aims to address these issues and expand the use of immunotherapy to more cancer types.
Immunotherapy has revolutionized the field of oncology, providing a new therapeutic approach for various cancers. Understanding its principles and applications is crucial for physicians in modern healthcare. Despite the challenges, the future of immunotherapy holds great promise, with ongoing research seeking to enhance its efficacy and expand its use.
1.
A US health panel advises starting mammograms at age 40 rather than 50.
2.
TULSA Is Effective in Long-Term Prostate Cancer Control.
3.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
4.
In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".
5.
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
1.
Molecular Matching for Individualized Blood-Disorder Therapy
2.
Everything You Need To Know About Melanoma Choroid: Causes, Symptoms, and Treatment
3.
Drug Safety Surveillance of Long-Term Medication Effects in Cancer Survivorship
4.
HPV-Related Cervical Cancer: Advances in Screening, Preventiofn & Treatment
5.
Early Diagnosis of Lung Cancer Through Emerging Biomarkers
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- The Incidence of Cancer in Men
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation